Your browser doesn't support javascript.
loading
Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia.
Li, Quanfu; Jin, Gaowa; Jiang, Caihong; Zhang, Zewei; Hou, Jixiang; Zhao, Juan; Chen, Feng; Li, Zhenhao.
Afiliação
  • Li Q; Department of Medical Oncology, Ordos Central Hospital, China.
  • Jin G; Department of Medical Oncology, Ordos Central Hospital, China.
  • Jiang C; Department of Medical Oncology, Ordos Central Hospital, China.
  • Zhang Z; Department of Radiation Oncology, Sun Yat-sen University Cancer Centre; State Key Laboratory of Oncology in South China; Collaborative Innovation Centre for Cancer Medicine, China.
  • Hou J; Department of Medical Oncology, Ordos Central Hospital, China.
  • Zhao J; Department of Medical Oncology, Ordos Central Hospital, China.
  • Chen F; Department of Medical Oncology, Ordos Central Hospital, China.
  • Li Z; School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Arch Med Sci ; 17(5): 1440-1446, 2021.
Article em En | MEDLINE | ID: mdl-34522277
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Arch Med Sci Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Arch Med Sci Ano de publicação: 2021 Tipo de documento: Article